Alpha 2.0
Login Register
» Journals » J Antimicrob Chemother

The Journal of Antimicrobial Chemotherapy

The Journal of Antimicrobial Chemotherapy is a renowned scientific journal that publishes cutting-edge research on the development, evaluation, and clinical application of antimicrobial agents. With a focus on combating infectious diseases, this journal provides a platform for researchers and clinicians to share their findings, advancements, and insights in the field of antimicrobial chemotherapy.
Details
Abbr. J Antimicrob Chemother
Publisher Oxford University Press
Start 1975
End Continuing
Frequency Monthly
p-ISSN 0305-7453
e-ISSN 1460-2091
Country United Kingdom
Language English
Specialty Infectious Diseases
Metrics
h-index / Ranks: 534 221
SJR / Ranks: 2572 1271
CiteScore / Ranks: 1714 9.20
JIF / Ranks: 1476 5.2
Recent Articles
11.
Comparison of antibiotic provision associated with acute sore throat symptom management in community pharmacies in Wales and England: a natural policy experiment
Matuluko A, Mantzourani E, Ahmed H, Cannings-John R, Evans A, Lalani M, et al.
J Antimicrob Chemother . 2025 Mar; PMID: 40071595
Background: Acute sore throat is managed in community pharmacies in England and Wales under different clinical pathways: Acute Sore Throat Pharmacy First (ASTPF) and Sore Throat Test and Treat (STTT),...
12.
Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?-authors' response
Baltas I, Patel T, Lima Soares A
J Antimicrob Chemother . 2025 Mar; PMID: 40068839
No abstract available.
13.
Comment on: Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?
Longshaw C, Dejonge B, Yamano Y
J Antimicrob Chemother . 2025 Mar; PMID: 40068838
No abstract available.
14.
Comment on: Resistance profiles of carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?
Rawson T, Al-Hassan M, Brzeska-Trafny I, Morkowska A, Jauneikaite E, Saman R, et al.
J Antimicrob Chemother . 2025 Mar; PMID: 40068836
No abstract available.
15.
Intraventricular injection of eravacycline in the treatment of carbapenem-resistant Acinetobacter baumannii meningitis: a case report
Liu Q, Zhou X, Du Z, Wang X, Li N
J Antimicrob Chemother . 2025 Mar; PMID: 40067915
No abstract available.
16.
Antibiotic-induced stress responses in Gram-negative bacteria and their role in antibiotic resistance
Brand C, Newton-Foot M, Grobbelaar M, Whitelaw A
J Antimicrob Chemother . 2025 Mar; PMID: 40053699
Bacteria adapt to changes in their natural environment through a network of stress responses that enable them to alter their gene expression to survive in the presence of stressors, including...
17.
Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trial
Yan T, Wang J, Zhu R, Ma D, Gao J, Wang J, et al.
J Antimicrob Chemother . 2025 Mar; PMID: 40048654
Background: Helicobacter pylori eradication in penicillin-allergic patients presents challenges. Options of effective regimens are lacking in areas where tetracycline is unavailable. Objectives: To evaluate the efficacy of replacing the proton...
18.
Identification of the czc metal efflux operon on a new plasmid type in a Pseudomonas aeruginosa clinical isolate belonging to ST357 O11
Valcek A, Strachinaru D, Soentjens P, Stoefs A, Van der Henst C
J Antimicrob Chemother . 2025 Mar; PMID: 40042181
No abstract available.
19.
In vivo evaluation of cefazolin inoculum effect in the treatment of experimental Staphylococcus aureus pneumonia with cefazolin
Lee S, Lee S, Park S, Lee J, Lee S
J Antimicrob Chemother . 2025 Mar; PMID: 40037650
Objectives: This study compared the efficacy of cefazolin in a mouse pneumonia model caused by a methicillin-susceptible Staphylococcus aureus (MSSA) strain with cefazolin inoculum effect (CIE) and its blaZ-eliminated derivative....
20.
Cellular pharmacology of tenofovir alafenamide and emtricitabine in neutrophils and platelets in people with and without HIV
Mainella V, Branchford B, Nemkov T, Hosford S, Coyle R, Johnson B, et al.
J Antimicrob Chemother . 2025 Mar; PMID: 40037647
Background: Previous studies have primarily focused on nucleos(t)ide reverse transcriptase inhibitor pharmacology in peripheral blood mononuclear cells (PBMCs) and erythrocytes via dried blood spots (DBS), but not other major blood...